SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PAPI, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.213
AS - Asia 17.291
EU - Europa 10.261
SA - Sud America 3.400
AF - Africa 322
OC - Oceania 153
Continente sconosciuto - Info sul continente non disponibili 24
Totale 66.664
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.589
SG - Singapore 7.143
CN - Cina 4.297
BR - Brasile 2.800
HK - Hong Kong 2.125
IT - Italia 2.020
UA - Ucraina 1.853
DE - Germania 1.773
VN - Vietnam 1.136
TR - Turchia 1.091
GB - Regno Unito 1.059
FI - Finlandia 729
NL - Olanda 659
RU - Federazione Russa 610
SE - Svezia 523
ID - Indonesia 456
MX - Messico 323
PL - Polonia 252
IN - India 248
AR - Argentina 243
CA - Canada 232
FR - Francia 201
AU - Australia 135
ZA - Sudafrica 121
BD - Bangladesh 117
JP - Giappone 116
AT - Austria 113
EC - Ecuador 100
ES - Italia 94
IQ - Iraq 84
BE - Belgio 69
CO - Colombia 61
KR - Corea 61
LT - Lituania 60
PY - Paraguay 58
PK - Pakistan 57
TW - Taiwan 55
CZ - Repubblica Ceca 47
VE - Venezuela 41
EG - Egitto 39
MA - Marocco 39
KE - Kenya 36
PE - Perù 34
UZ - Uzbekistan 31
AE - Emirati Arabi Uniti 30
IE - Irlanda 27
CH - Svizzera 26
CL - Cile 26
MY - Malesia 26
UY - Uruguay 25
SA - Arabia Saudita 22
TH - Thailandia 21
TN - Tunisia 21
DZ - Algeria 20
IR - Iran 20
PH - Filippine 19
PT - Portogallo 18
KZ - Kazakistan 17
NZ - Nuova Zelanda 17
AL - Albania 16
IL - Israele 15
JO - Giordania 15
EU - Europa 13
GR - Grecia 13
NP - Nepal 13
DO - Repubblica Dominicana 12
HR - Croazia 12
RO - Romania 12
LB - Libano 11
RS - Serbia 10
BG - Bulgaria 9
BO - Bolivia 9
HU - Ungheria 9
XK - ???statistics.table.value.countryCode.XK??? 9
AZ - Azerbaigian 8
HN - Honduras 8
MK - Macedonia 8
NG - Nigeria 8
VI - Stati Uniti Isole Vergini 8
GE - Georgia 7
JM - Giamaica 7
CR - Costa Rica 6
DK - Danimarca 6
GT - Guatemala 6
PA - Panama 6
PS - Palestinian Territory 6
TT - Trinidad e Tobago 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
BN - Brunei Darussalam 5
MD - Moldavia 5
MN - Mongolia 5
BY - Bielorussia 4
CG - Congo 4
ET - Etiopia 4
KH - Cambogia 4
LV - Lettonia 4
OM - Oman 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
Totale 66.590
Salva come PNG Salva come JPEG
Città #
Fairfield 4.047
Singapore 3.861
Woodbridge 3.629
Ashburn 3.225
Houston 2.634
Hong Kong 2.105
Jacksonville 2.039
Chandler 1.631
Santa Clara 1.557
Seattle 1.514
Wilmington 1.435
Ann Arbor 1.327
Cambridge 1.319
Dallas 1.247
Beijing 1.188
Izmir 700
Nanjing 635
Princeton 564
Los Angeles 520
Munich 519
Ho Chi Minh City 375
San Diego 370
Jakarta 357
Ferrara 344
New York 313
Boardman 308
Milan 279
Washington 237
Hanoi 231
São Paulo 229
Warsaw 227
Mexico City 225
Chicago 213
Nanchang 194
Shanghai 191
Shenyang 170
Tianjin 169
Helsinki 160
Hefei 154
Moscow 141
London 137
Addison 131
Buffalo 127
Hebei 124
Changsha 111
Dearborn 108
Jiaxing 100
Nuremberg 99
Rome 98
Lappeenranta 96
Turku 93
Dong Ket 90
Rio de Janeiro 89
Tokyo 87
Mountain View 86
Council Bluffs 80
Falls Church 79
Redwood City 74
Brooklyn 72
Falkenstein 72
Zhengzhou 70
Toronto 68
Frankfurt am Main 66
Norwalk 66
Denver 65
Boston 64
The Dalles 62
Bologna 59
Belo Horizonte 58
Guangzhou 58
Montreal 58
Vienna 58
Chennai 52
Jinan 52
Kunming 50
Bremen 49
Da Nang 49
Stockholm 49
Atlanta 48
Ningbo 48
Johannesburg 47
San Francisco 47
Brussels 46
Orange 46
Haiphong 45
Verona 45
Phoenix 43
Curitiba 42
Orem 42
Campinas 40
Brasília 38
Manchester 38
Amsterdam 36
Columbus 36
San Mateo 36
Americana 35
Ankara 34
Poplar 34
Porto Alegre 34
Baghdad 33
Totale 44.482
Salva come PNG Salva come JPEG
Nome #
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 636
Asthma 452
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 382
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 317
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 314
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 311
Targeting Th2 cells in asthmatic airways 276
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 264
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial 257
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 257
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 237
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 223
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 219
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 214
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 211
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 209
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 207
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 205
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 204
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 203
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 198
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 198
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 196
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 194
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 192
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 189
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 188
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 188
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma 188
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 187
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 185
Malattie polmonari primitive da cause dismetaboliche. 183
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 182
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS) 179
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 178
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 178
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 176
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 175
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial 174
Activation of NF-kappaB transcription factor in asthma death 172
Intravenous N-acetylcysteine in respiratory disease with abnormal mucus secretion 171
Models of infection and exacerbations in COPD. 171
COPD: early diagnosis and treatment to slow disease progression 171
A new combination therapy for asthma: bridging the gap between effectiveness in trials and clinical practice? 171
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 171
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 170
Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD 170
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 170
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 170
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 169
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 169
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 169
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 169
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 168
A defective type 1 response to rhinovirus in atopic asthma 165
Rhinovirus vaccination: the case against 165
Management of bronchial asthma 163
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells 163
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 163
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 163
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 162
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 162
A serum proteome signature to predict mortality in severe COVID-19 patients 162
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 161
Asthma management 161
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis 160
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 160
A Novel Insight into Adaptive Immunity in Chronic Obstructive Pulmonary Disease B Cell Activating Factor Belonging to the Tumor Necrosis Factor Family 160
Enfisema polmonare: prospettive di terapia 159
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 159
INSTEAD: A randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD 159
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 158
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 158
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 157
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 157
Xanthine oxidase activation by HRV16 infection in respiratory epithelial cells 156
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease 156
A randomized, double-blinded, double-dummy efficacy and safety study of budesonide-formoterol Spiromax® compared to budesonide-formoterol Turbuhaler® in adults and adolescents with persistent asthma 156
Mechanisms of rhinovirus-induced asthma 156
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 155
Extrafine beclometasone diproprionate/formoterol fumarate: A review of its effects in chronic obstructive pulmonary disease 155
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 155
Tubercolosi extrapolmonare a carico dell’apparato genitale femminile con reazione a catena polimerasica negativa per micobatterio tubercolare. 154
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 154
Viral infections in exacerbations of asthma and chronic obstructive pulmonary disease. 154
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 154
An unusual case of congenital short trachea with very long bronchi mimicking bronchial asthma 154
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 154
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 154
Severe Pneumonia following intravescical BCG therapy in a patient with bladder cancer. 153
True tracheal bronchus 153
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 152
Apporto esogeno di riducenti e attività del rinovirus HRV16 152
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies 151
Cellule staminali e patologia polmonare dell’adulto 150
COPD exacerbations: definitions and classifications 150
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma. 150
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. 150
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 150
Totale 18.918
Salva come PNG Salva come JPEG
Categoria #
all - tutte 346.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 15.902
Totale 362.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.205 0 0 0 0 0 681 279 751 170 784 881 659
2021/20225.146 219 452 320 258 197 236 283 293 204 380 461 1.843
2022/20234.213 575 103 145 491 619 645 179 385 531 65 314 161
2023/20242.742 248 267 113 83 137 279 78 136 88 259 348 706
2024/202511.287 303 293 998 331 1.307 813 351 716 1.934 1.653 1.447 1.141
2025/202617.838 2.708 1.677 3.921 4.389 4.661 482 0 0 0 0 0 0
Totale 67.916